Allergan PLC and Paratek Pharmaceuticals Inc. had the only positive acne data out of four later-stage programs that have reported results so far in 2017 when the partners unveiled Phase III results for sarecycline, a potentially safer cycline oral antibiotic.
Allergan/Paratek, Xenon Pharmaceuticals Inc. and Foamix Pharmaceuticals Ltd. all reported acne clinical trial data in late March, but...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
